INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Early Phase Oncology Site Network: Benefits Of A Personal Touch
Choose a site network built on partnership — not volume — to drive smoother early-phase oncology trials and deliver better outcomes for sponsors, sites, and patients.
-
The Role Of Company Culture In FSP Partnerships
This piece explores intentional culture-building as a strategic asset in FSP engagements, transforming transactional relationships into enduring, high-performing partnerships.
-
Building Bioanalysis Infrastructure For Modern Drug Development
Drug development accelerates with AI, decentralized trials, and adaptive protocols, but legacy CRO infrastructure lags. Platform-based systems enable speed, quality, automation, and continuous improvement.
-
CDMO Support: Success In Early-Phase Drug Product Development
As sponsors strive to deliver therapies with increasing efficiency, CDMOs are poised to remain vital, offering specialized expertise, accelerated timelines, cost efficiency, and risk mitigation.
-
Unified Patient Apps: The Future Of Trial Simplicity11/12/2025
A unified patient app streamlines clinical trial participation by combining scheduling, questionnaires, travel, and payments—reducing burden, improving engagement, and supporting better retention and data quality.
-
Successful Manufacturing Of Clinical Trial Supply8/27/2024
Formulation and pharmacy experts share their secrets for completing clinical trials and resolving issues that could impact your drug development program’s timeline.
-
Dispelling Common Clinical Trial Oversight Myths6/17/2025
Many clinical trial oversight problems can be avoided or mitigated by sponsor understanding root causes and being a proactive collaborator with its partners.
-
Community-Focused Site Networks Transforming Clinical Trials3/20/2025
Leveraging a site network has proven to ease study enrollment, contracting, and budgeting, while also reducing overall study cost and timelines.
-
Productivity Hacks For An Effective RFP / Clinical Trial Vendor Selection7/1/2025
Starting a new clinical study requires careful vendor selection and these practical, actionable steps to enhance your selection process and ensure long-term partnership alignment.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
At IQVIA Biotech, our extensive oncology expertise, coupled with the ability to leverage IQVIA’s vast data, technology, and analytics resources, creates a clinical development partner perfect for you.
-
Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.
-
Ropack Pharma Solutions offers turnkey primary and secondary pharmaceutical packaging services of solid oral dosages into blisters, bottles, flip-top vials, stick-packs and sachets.
-
Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.
-
One Home for Sites is a vendor-agnostic, sponsor-agnostic, aggregation platform that provides single sign-on and more. Become part of the only industry-wide solution to site tech overload.